newsfilter
← Latest News
GlobeNewswire·

OpGen Submits De Novo request to the U.S. FDA for Unyvero Urinary Tract Infection Panel

Based on large multi-center study with over 1,800 patient samplesPrimary endpoint for Unyvero UTI for urinary tract infection was successfully met and shows overall weighted average sensitivity of 96.8% and overall